iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA)
IDNA is a passive ETF by iShares tracking the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. IDNA launched on Jun 11, 2019 and has a 0.47% expense ratio.
ETF Info
US46435U1925
46435U192
Jun 11, 2019
North America (U.S.)
1x
NYSE FactSet Global Genomics and Immuno Biopharma Index
Multi-Cap
Blend
Expense Ratio
IDNA has an expense ratio of 0.47%, placing it in the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) returned -12.46% year-to-date (YTD) and -17.61% over the past 12 months.
IDNA
-12.46%
3.39%
-13.35%
-17.61%
-10.36%
N/A
^GSPC (Benchmark)
1.30%
12.94%
1.49%
12.48%
15.82%
10.87%
Monthly Returns
The table below presents the monthly returns of IDNA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.75% | -1.32% | -8.93% | 2.59% | -5.76% | -12.46% | |||||||
| 2024 | -3.13% | 8.61% | -0.54% | -6.19% | 4.96% | -2.04% | 7.27% | 0.64% | -1.39% | -1.97% | 2.45% | -8.02% | -0.73% |
| 2023 | 7.03% | -10.62% | -3.36% | 0.73% | 1.71% | -1.76% | 2.68% | -6.18% | -9.55% | -10.96% | 13.85% | 12.37% | -7.63% |
| 2022 | -17.12% | -4.21% | -0.95% | -13.64% | -3.63% | 1.28% | 9.55% | -6.26% | -11.08% | 3.26% | 3.27% | -10.55% | -42.28% |
| 2021 | 9.60% | -6.63% | -2.77% | 4.90% | -2.34% | 11.22% | -3.69% | 7.50% | -5.87% | -2.01% | -4.53% | -7.12% | -3.98% |
| 2020 | -6.40% | 3.61% | -7.23% | 17.68% | 13.47% | 6.08% | -1.71% | 2.20% | 2.15% | -2.64% | 17.85% | 2.85% | 54.30% |
| 2019 | 9.07% | 1.76% | -6.63% | -5.11% | 5.88% | 12.32% | 3.33% | 20.83% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of IDNA is 3, meaning it’s performing worse than 97% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund provided a 1.12% dividend yield over the last twelve months, with an annual payout of $0.22 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.22 | $0.22 | $0.24 | $0.14 | $0.31 | $0.12 | $0.24 |
Dividend yield | 1.12% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.22 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.24 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.31 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.12 |
| 2019 | $0.24 | $0.24 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund was 68.26%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund drawdown is 63.19%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.26% | Sep 3, 2021 | 541 | Oct 27, 2023 | — | — | — |
| -26.93% | Mar 5, 2020 | 8 | Mar 16, 2020 | 23 | Apr 17, 2020 | 31 |
| -22.23% | Feb 9, 2021 | 19 | Mar 8, 2021 | 107 | Aug 9, 2021 | 126 |
| -14.38% | Jul 19, 2019 | 58 | Oct 9, 2019 | 30 | Nov 20, 2019 | 88 |
| -13.58% | Jul 21, 2020 | 35 | Sep 8, 2020 | 23 | Oct 9, 2020 | 58 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...